DURECT Corporation (NASDAQ: DRRX)
$1.37
+0.0150 ( +1.11% ) 25.5K
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
Market Data
Open
$1.37
Previous close
$1.35
Volume
25.5K
Market cap
$42.21M
Day range
$1.30 - $1.40
52 week range
$0.47 - $5.04
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Jun 28, 2024 |
8-k | 8K-related | 15 | May 21, 2024 |
10-q | Quarterly Reports | 60 | May 14, 2024 |
8-k | 8K-related | 12 | May 13, 2024 |
8-k | 8K-related | 12 | Apr 30, 2024 |
10-k | Annual reports | 90 | Mar 28, 2024 |
8-k | 8K-related | 12 | Mar 27, 2024 |
8-k | 8K-related | 11 | Mar 22, 2024 |
8-k | 8K-related | 13 | Mar 04, 2024 |
8-k | 8K-related | 12 | Dec 22, 2023 |